Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0580
-0.0010 (-1.69%)
At close: Mar 11, 2026
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 60.99 million as of March 11, 2026. Its market cap has increased by 64.63% in one year.
Market Cap
60.99M
Enterprise Value
51.49M
Revenue
4.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 60.99M, an increase of 965.38%. That is a compound annual growth rate of 8.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 60.99M | -30.95% |
| Dec 31, 2025 | 88.33M | 119.36% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 81.80M |
| Cynata Therapeutics | 80.73M |
| Alterity Therapeutics | 76.13M |
| Imugene | 75.56M |
| Radiopharm Theranostics | 74.43M |
| Neurizon Therapeutics | 57.29M |
| Amplia Therapeutics | 56.44M |
| Proteomics International Laboratories | 53.68M |